Facial iD Customized Mandible Reconstruction Plates

April 21, 2026 updated by: Stryker Craniomaxillofacial

Stryker Customized Plates for Mandibular Reconstruction: A Retrospective Post Market Follow Up to Confirm Safety and Performance of Facial iD Customized Mandible Reconstruction Plates

A retrospective post market follow up to confirm the safety and performance of Stryker's Customized Plates for Mandibular Reconstruction. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Study Overview

Detailed Description

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker Customized Plates for Mandibular Reconstruction (CMRP) in the clinical setting. his study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. The Customized Mandible Recon Plate Kit is indicated for use in primary mandibular reconstruction with bone graft, temporary bridging until delayed secondary reconstruction and secondary mandibular reconstruction. Up to 3 investigational sites in US will be participating. Based on a non-inferiority study power calculation 80 subjects will be enrolled in the study. The primary outcome parameter evaluating successful reconstruction of the mandible without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29403
        • Head & Neck Surgery Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Description

Inclusion Criteria:

  1. Patients who underwent primary or secondary mandibular reconstruction using a Stryker Facial iD CMRP implant as per routine clinical practice.
  2. Patients for whom data on the primary outcome variable is available.

Exclusion Criteria:

  1. Patients with active local infections at the time of surgery
  2. Patients with known metal allergies and/or foreign body sensitivity at the time of surgery
  3. Potentially non-compliant patients who were unwilling or incapable of following post-operative care instructions
  4. Patients with inadequate bone quantity or quality necessary for plate fixation or stabilization at the time of surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of successful reconstruction of the mandible without the need for unplanned revision surgery
Time Frame: Data collected at a single time point per patient in the course of 16 months
Rate of unplanned revision surgery determined by reviewing adverse events in patient medical charts after surgery. Used to document whether an unplanned revision surgery was required or not for each patient.
Data collected at a single time point per patient in the course of 16 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of satisfactory occlusion achieved with orthodontic treatment.
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Assessed by review of individual patient medical records that document the rate of satisfactory occlusion achieved with orthodontic treatment.
Data collected at a single time point per patient in the course of 16 months.
Infection rate
Time Frame: Data collected at time points from patient medical charts in the course of 16 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points from patient medical charts in the course of 16 months.
Intraoperative complications
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Determined by adverse events reported from patient medical charts.
Data collected at a single time point per patient in the course of 16 months.
Postoperative complications
Time Frame: Data collected at time points per patient in the course of 16 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points per patient in the course of 16 months.
Any known adverse events
Time Frame: Data collected at time points per patient in the course of 16 months.
Determined by adverse events reported from patient medical charts.
Data collected at time points per patient in the course of 16 months.
Rate of plate or screw failure
Time Frame: Data collected at time points point per patient in the course of 16 months.
Determined by rate of adverse events reported from patient medical charts involving plate or screw fracture.
Data collected at time points point per patient in the course of 16 months.
Operating room (OR) time
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Time patients are operated (dd:hh)
Data collected at a single time point per patient in the course of 16 months.
Time to return to solid food/normal diet
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Time for patient to return to solid food/normal diet post operation (dd)
Data collected at a single time point per patient in the course of 16 months.
Hospitalization time: ICU and normal ward
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Time the patient was hospitalized post procedure (dd:hh)
Data collected at a single time point per patient in the course of 16 months.
EuroQol-5 Domain Questionnaire (if available)
Time Frame: Data collected at time points per patient in the course of 16 months.
A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).
Data collected at time points per patient in the course of 16 months.
End user questionnaire
Time Frame: Data collected during the course of 16 months.
Questionnaire only for medically trained professionals on site staff using the device. Questions relate to subjective rating of ease of use by the surgeon if compared to stock plates (evaluated per treating surgeon, not per patient). Questionnaire is qualitative response regarding the ease of use of the device.
Data collected during the course of 16 months.
Misfit of implant
Time Frame: Data collected at time points per patient in the course of 16 months.
Fit of implant Time for adaptations
Data collected at time points per patient in the course of 16 months.
Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)
Time Frame: Data collected at time points per patient in the course of 16 months.
40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.
Data collected at time points per patient in the course of 16 months.
12-Item Short Form Health Survey (SF-12)
Time Frame: Data collected at time points per patient in the course of 16 months.
12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.
Data collected at time points per patient in the course of 16 months.
Visual Analogue Scale (VAS) Pain
Time Frame: Data collected at time points per patient in the course of 16 months.
The visual analogue scale (VAS) is a psychometric response scale. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). 100-mm VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.
Data collected at time points per patient in the course of 16 months.
Ischemia time
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Ischemia time (dd:hh)
Data collected at a single time point per patient in the course of 16 months.
Frequency of Maxilla-mandibular fixation
Time Frame: Data collected at time points per patient in the course of 16 months.
Number of maxillo-mandibular fixation procedures (number per patient).
Data collected at time points per patient in the course of 16 months.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical approach
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Surgical approach taken for the procedure. Including: transoral; transbuccal; submandibular; preauricular; other
Data collected at a single time point per patient in the course of 16 months.
Follow-up time
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visits.
Data collected at a single time point per patient in the course of 16 months.
Flap used
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Type of flap used: vascularized fibula flap, vascularized scapula flap, vascularized iliac crest flap, avascularized fibula flap, avascularized scapula flap, avascularized iliac crest flap, others
Data collected at a single time point per patient in the course of 16 months.
Radiation
Time Frame: Data collected at time points per patient in the course of 16 months.

Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts.

Radiation therapy performed on the anatomical area treated with the device. Any postoperative radiation therapy recorded in patient medical charts.

Data collected at time points per patient in the course of 16 months.
Dental reconstruction in a single stage surgery
Time Frame: Data collected at time points per patient in the course of 16 months.
Data for dental reconstruction collected from patient medical charts.
Data collected at time points per patient in the course of 16 months.
Sterilization method used
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Sterilization method used for the device.
Data collected at a single time point per patient in the course of 16 months.
Fixation system used
Time Frame: Data collected at a single time point per patient in the course of 18 months.

System used to fix the device during the procedure. Stryker Universal Mandible System; other

Types and number of screws

Data collected at a single time point per patient in the course of 18 months.
Plate types
Time Frame: Data collected at a single time point per patient in the course of 16 months.
2.0 or 2.8 plates used Hemi or full reconstruction plate used
Data collected at a single time point per patient in the course of 16 months.
Patient age
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Age (years)
Data collected at a single time point per patient in the course of 16 months.
Gender
Time Frame: Data collected at a single time point per patient in the course of 16 months
Responses: Male, Female, undifferentiated, unknown
Data collected at a single time point per patient in the course of 16 months
Primary indication for the surgery / diagnosis
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Diagnosis collected from patient medical charts.
Data collected at a single time point per patient in the course of 16 months.
Relevant Medical conditions
Time Frame: Data collected at time points per patient in the course of 16 months.
Descriptive data of any underlying medical conditions and medications recorded in patient medical charts that may be related to the device or primary outcome (qualitative measure).
Data collected at time points per patient in the course of 16 months.
Primary/secondary reconstruction performed
Time Frame: Data collected at time points point per patient in the course of 16 months
Type of reconstruction procedure performed (e.g. immediately or after an initial surgery).
Data collected at time points point per patient in the course of 16 months
Localization of the defect
Time Frame: Data collected at time points point per patient in the course of 16 months.
Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; other
Data collected at time points point per patient in the course of 16 months.
Patient height
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Height (cm, feet, inches)
Data collected at a single time point per patient in the course of 16 months.
Patient weight
Time Frame: Data collected at a single time point per patient in the course of 16 months.
Weight (kg, lb)
Data collected at a single time point per patient in the course of 16 months.
Year smoking was stopped
Time Frame: Data collected at time points per patient in the course of 16 months.
Year smoking was stopped (YYYY)
Data collected at time points per patient in the course of 16 months.
Smoking frequency
Time Frame: Data collected at time points per patient in the course of 16 month
The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).
Data collected at time points per patient in the course of 16 month
Smoking duration
Time Frame: Data collected at time points per patient in the course of 16 month
Duration of smoking (pack years)
Data collected at time points per patient in the course of 16 month
Years of active smoking
Time Frame: Data collected at time points per patient in the course of 16 month
Total number of years active smoker (YY)
Data collected at time points per patient in the course of 16 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Actual)

April 4, 2026

Study Completion (Actual)

April 4, 2026

Study Registration Dates

First Submitted

July 31, 2025

First Submitted That Met QC Criteria

November 17, 2025

First Posted (Actual)

November 24, 2025

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mandible; Deformity

Clinical Trials on Mandibular reconstruction

Subscribe